<unk>  is one of the most widely<unk> d drugs in the world. In the United States, between 42% and 49% of people have<unk> d<unk> , an estimated 9% of those who<unk> <unk>  develop dependence. Of Australians aged 14 years and over 34.8% have<unk> d<unk>  one or more times in their life. In the U.S.,<unk>  is the most commonly identified illicit substance<unk> d by people admitted to treatment facilities. Most of these people were referred there by the criminal justice system. Of admittees 16% either went on their own, or were referred by family or friends. In the European Union (data as available in 2018, information for individual countries was collected between 2012 and 2017), 26.3% of adults aged 15–64<unk> d<unk>  at least once in their lives, and 7.2%<unk> d<unk>  in the last year. The highest prevalence of<unk> <unk>  among 15 to 64 years old in the EU was reported in France, with 41.4% having<unk> d<unk>  at least once in their life, and 2.17%<unk> d<unk>  daily or almost daily. Among young adults (15–34 years old), 14.1%<unk> d<unk>  in the last year. Among adolescents (15–16 years old) in a European school based study (ESPAD), 16% of students have<unk> d<unk>  at least once in their life, and 7% (boys: 8%, girls: 5%) of students had<unk> d<unk>  in the last 30 days. Globally, 22.1 million people (0.3% of the worlds population) were estimated to suffer from<unk>  dependence.
Cannabis use disorder
Benzodiazepine use disorder
Stimulant use disorder
Opioid use disorder
Amphetamine dependence
Benzodiazepine dependence
Polysubstance dependence
Substance dependence